The Effect of topical medication containing benzalkonium chloride on ocular surface disease in glaucoma patients

• Main Authors: Nurwasis, -, Rina Wulandari, -, Delfitri Lutfi, -
• Format: Article PeerReviewed
• Language: English; English; English; English
• Published: Hampstead Psychological Associates 2020
• Subjects: R Medicine (General); RE Ophthalmology
• Online Access: http://repository.unair.ac.id/104158/1/The%20effect%20of%20topical%20medication%20containingbenzalkoniumchloride%20on%20ocular%20surface%20disease%20inglaucoma%20ptatients.pdf; http://repository.unair.ac.id/104158/2/The%20Effect%20of%20Topical.pdf; http://repository.unair.ac.id/104158/3/The%20effect%20of%20topical%20medication%20containingbenzalkoniumchloride%20on%20ocular%20surface%20disease%20inglaucoma%20ptatients.pdf; http://repository.unair.ac.id/104158/6/Bukti%20Korespondensi%205.pdf; http://repository.unair.ac.id/104158/; https://www.psychosocial.com/article/PR200725/10776/; https://doi.org/10.37200/IJPR/V24I2/PR200725
• Institution: Universitas Airlangga

Background, The main cause of the emergence of dry eye and ocular surface disease (OSD) is strongly suspected due to the preservative component of topical medication in the form of benzalkonium chloride(BAK).Various complaints such as uncomfortable, teary, redness, burning and foreign object sensati...